Thai Officials Say Compulsory Licenses Will Not Deter Biotech Business – BIO 2008 Exclusive
This article was originally published in PharmAsia News
Executive Summary
SAN DIEGO - Industry furor over Thailand's compulsory license position will not deter multinational companies from investing in the country, according to Thai officials who sat down with PharmAsia News during the BIO 2008 convention in San Diego
You may also be interested in...
Thailand Probes Compulsory License Clopidogrel Purchasing Woes
Thailand’s Government Pharmaceutical Organization has faced heat from the health ministry over its attempts to buy blood thinner clopidogrel under a compulsory license issued for Sanofi’s Plavix in 2007. The issue is at the heart of the country’s attempts to provide universal health care without costs spiraling out of control.
Thailand Probes Compulsory License Clopidogrel Purchasing Woes
Thailand’s Government Pharmaceutical Organization has faced heat from the health ministry over its attempts to buy blood thinner clopidogrel under a compulsory license issued for Sanofi’s Plavix in 2007. The issue is at the heart of the country’s attempts to provide universal health care without costs spiraling out of control.
Thailand Furthers Cost-Cutting Measures, Putting Additional Pressure On MNCs
The Thai government plans to institute more cost-cutting measures on drugs and services in the country – a plan that will put a tighter squeeze on MNCs operating in Thailand.